Condition
Acute Exacerbation Chronic Obstructive Pulmonary Disease
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (1)
P 3 (1)
Trial Status
Not Yet Recruiting3
Completed2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07456176Phase 3Not Yet RecruitingPrimary
Effect of Low-Dose Versus High-Dose Alpha-Lipoic Acid on Oxidative Stress, Inflammation, and Clinical Outcomes in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
NCT07416266Completed
Lower Respiratory Tract Infections Managed in Primary Care in France
NCT07125664Phase 2Not Yet RecruitingPrimary
Intravenous Alpha-1 Antitrypsin for Hospitalized Patients With COPD Exacerbations (AECOPD Study)
NCT06779344Not ApplicableNot Yet RecruitingPrimary
MxA and CRP-Guided Use of Antimicrobial Agents for AECOPD
NCT02114567Not ApplicableCompletedPrimary
Is it Necessary to Set External PEEP in AECOPD Patients
Showing all 5 trials